Posts classified under: Image

VASCage researchers find cardiometabolic microRNA biomarkers that may aid in COVID-19 severity and mortality prediction

The study was conducted by VASCage project leader Prof. Manuel Mayr and his team including first author and PhD student Dr. Clemens Gutmann, who studied and practiced medicine at the Medical University of Innsbruck before joining Prof. Mayr’s group at King’s College London. In collaboration with researchers from VASCage company partner TAmiRNA GmbH in Vienna they contribute with their recent findings to fight the pandemic. They have published their results in ‘Cardiovascular Research‘, the Read More

PRESS RELEASE: Blood vessels already suffer in youth. New VASCage publication on cardiovascular risk factors in Journal JAHA

Risk factors for heart attack and stroke such as blood and liver fat levels lead to an increase in early pathological vascular wall changes in Tyrolean adolescents. This has been shown in a representative study of Tyrolean and South Tyrolean adolescents. A recent publication by the VASCage research center and the Medical University of Innsbruck concludes that preventive care would be important not only for high-risk adolescents. Read More

VASCage is research partner in the European ExerGetic project. The goal is to prevent falls in geriatric patients with a whole-body videogame-based training device

Fall prevention is of utmost importance not only in stroke rehabilitation. According to the World Health Organization (WHO) around 28-35% of people aged 65 years and older fall each year. Experiences of falls are considered as stressful events which can lead to drastic consequences in social interaction, daily activities, and quality of life. Read More

VASCage science outreach: Series of high school workshops on artificial intelligence in medicine and vascular research

VASCage regularly engages in activities to promote public awareness and understanding of science, especially for high school students and their teachers. Together with the Tyrolean science outreach association ‚klasse!forschung‘ VASCage initiated a workshop series inspiring young people to develop an interest in research.

Junior researcher Nadja Gruber is mathematician and specialist for Read More

VASCage Proteomics and RNA biomarker research contributes with a new publication to fight the pandemic

A ‘Nature Communications‘ paper on prognostic COVID-19 biomarkers for intensive care patients has been published.
COVID-19 poses an unprecedented challenge to health care systems globally. It is increasingly apparent that conventional prognostic scores for patients admitted to intensive care units (ICUs) are unsuitable for outcome prediction. Now VASCage project leader Manuel Mayr of King’s College London, and his team were able to make important contributions to address this clinicial need. Read More

PRESS RELEASE:  First signs of atherosclerosis in Tyrolean Youths? Largest clinical trial on vascular health in adolescents in Austria

EVA4YOU is an observational study enrolling students and apprentices aged between 14 and 19 years to determine predictors of the early steps of the formation of atherosclerosis. Examinations are conducted at schools and companies throughout Tyrol.
Link to press release (in German)
Download press picture 1 ©VASCage/M.Knoflach
Download press picture 2 ©VASCage/M.Knoflach
Link to the trial EVA4YOU Read More

PRESS RELEASE: clinical trial ‘Post-stroke osteopathy’ on bone fractures after stroke

Patients who survive the acute phase of stroke are at a higher risk of bone fractures. VASCage has issued a press release on its new clinical trial ‘Post-Stroke Osteopathy’. The objective is to characterize falls and fractures and changes in the bone microstructure after  stroke.
Link to press release (in German)
Download press picture1 ©Walch
Download press picture2 ©Meier
Download press picture3 ©Degenhart

Link to the trial Post-Stroke Osteopathy

PRESS RELEASE: trial on new combination of drug, brain-stimulation and occupational therapy for stroke rehabilitation

VASCage has issued a press release on IMPULSE, a large clinical study, that is carried out together with Klinik Pirawarth, EVER Neuro Pharma GmbH and other VASCage scientific and company partners.
Link to press release (in German)
Download press picture ©Ines Schandl
Link to the trial IMPULSE

New research results on flies, mice and humans suggests that spermidine-rich diet might protect the ageing brain

Decreased cognitive performance is a hallmark of brain ageing, but the underlying mechanisms and potential therapeutic avenues remain poorly understood. Now, new research results with VASCage contribution raise the intriguing possibility that dietary spermidine may be protective against cognitive decline in humans. The exciting new findings are published in the current issue of the journal Cell Reports. Read More

VASCage GmbH company partners and scientific partners got together in our first virtual consortium meeting

Around 100 participants enjoyed the exciting talks on “Vascular Health in a Digital World” by our keynote speakers Sabine Klein (ÖGK), Winfried Ness (Helm AG) and Uwe Siebert (UMIT), the discussion with our VASCAge CSO Stefan Kiechl and the presentation of 16 project highlights! The participants also used the opportunity to network and chat in our virtual coffee area.
THANKS TO ALL OUR SPEAKERS AND PARTICIPANTS! Read More